FDA Drug Application (205412) for ABACAVIR SULFATE; LAMIVUDINE by HETERO LABS LTD V

Back to FDA Applications sponsored by HETERO LABS LTD V

Application Number205412
Product Number001
FormTABLET;ORAL
Dosage600;300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABACAVIR SULFATE; LAMIVUDINE
Active IngredientABACAVIR SULFATE;LAMIVUDINE



Back to FDA Applications sponsored by HETERO LABS LTD V

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.